3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
The S 500 is up an incredible 25% over the past 12 months, but not every stock in the benchmark index has participated in the rally. A handful of terrific healthcare stocks have fallen more than 25% from the peaks they set less than a year ago.
Shares of (NYSE: PFE), Bristol Myers Squibb (NYSE: BMY), and CVS Health (NYSE: CVS) are down, but their dividend programs are still going strong. Here's why investors can rely on these high-yield stocks to keep raising their payouts for at least another decade.
Shares of Pfizer are down about 31% over the past 12 months. The pharmaceutical company's development pipeline is producing new drugs, but the stock market can't get over how quickly sales collapsed for Comirnaty and Paxlovid, a COVID vaccine and antiviral treatment, respectively.
Source Fool.com
Pfizer Inc. Aktie
Die Community bevorzugt Pfizer Inc., mit deutlich mehr Buy- (29) als Sell-Einschätzungen (4).
Ein Kursziel von 41 € für Pfizer Inc. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 27.88 € bedeuten.
